Literature DB >> 18980619

Serologic findings in autoimmune hemolytic anemia associated with immunoglobulin M warm autoantibodies.

Patricia A Arndt1, Regina M Leger, George Garratty.   

Abstract

BACKGROUND: Autoimmune hemolytic anemia (AIHA) associated with immunoglobulin M (IgM) warm autoantibodies is unusual but often severe, with more fatalities than other types of AIHA. Diagnosing this type of AIHA can be difficult because routine serologic data are not always informative. STUDY DESIGN AND METHODS: Forty-nine cases of IgM warm AIHA in 25 years were studied by serologic methods.
RESULTS: Routine direct antiglobulin tests (DATs) detected red blood cell (RBC)-bound C3 in 90 percent of cases (65% had C3 but no immunoglobulin G [IgG] on their RBCs) and IgG in 24 percent. IgM was detected on 29 of 47 (62%) patients' RBCs; RBC-bound IgM was detected in 14 of 47 cases by a tube DAT method and in an additional 15 of 21 (71%) cases using fluorescein isothiocyanate anti-IgM and flow cytometry. Eighty-one percent of eluates from patients' RBCs reacted. Warm autoagglutinins were present in 94 percent of serum samples; untreated and enzyme-treated RBCs were hemolyzed at 37 degrees C by 13 and 65 percent of serum samples, respectively. Most agglutinins were optimally reactive at 30 to 37 degrees C. Patients' RBCs were spontaneously agglutinated in 78 percent of cases; washing with 37 degrees C saline or treating RBCs with dithiothreitol resolved this problem. Clear specificity of autoantibody was defined in 35 percent of serum samples.
CONCLUSION: IgM warm AIHA can be confused with cold agglutinin syndrome and "mixed/combined"-type AIHA; a serologic workup by a specialist reference laboratory can help with the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18980619     DOI: 10.1111/j.1537-2995.2008.01957.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  15 in total

1.  Diagnosis and management of newly diagnosed childhood autoimmune haemolytic anaemia. Recommendations from the Red Cell Study Group of the Paediatric Haemato-Oncology Italian Association.

Authors:  Saverio Ladogana; Matteo Maruzzi; Piera Samperi; Silverio Perrotta; Giovanni C Del Vecchio; Lucia D Notarangelo; Piero Farruggia; Federico Verzegnassi; Nicoletta Masera; Paola Saracco; Silvia Fasoli; Maurizio Miano; Gabriella Girelli; Wilma Barcellini; Alberto Zanella; Giovanna Russo
Journal:  Blood Transfus       Date:  2016-12-16       Impact factor: 3.443

2.  Pitfalls in the diagnosis of autoimmune haemolytic anaemia.

Authors:  Wilma Barcellini
Journal:  Blood Transfus       Date:  2015-01       Impact factor: 3.443

Review 3.  Treatment of autoimmune hemolytic anemias.

Authors:  Alberto Zanella; Wilma Barcellini
Journal:  Haematologica       Date:  2014-10       Impact factor: 9.941

Review 4.  Warm antibody autoimmune hemolytic anemia.

Authors:  Theodosia A Kalfa
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

5.  Autoantibody profile in sarcoidosis, analysis from the GRADS sarcoidosis cohort.

Authors:  Basheer Khassawneh; Chengsong Zhu; Briana Barkes; Brian Vestal; Sarah Shrock; May Gillespie; Karin Pacheco; Kevin D Deane; Lisa A Maier; Quan-Zhen Li; Nabeel Hamzeh
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

Review 6.  The role of serological and molecular testing in the diagnostics and transfusion treatment of autoimmune haemolytic anaemia.

Authors:  Mirela Raos; Marija Lukic; Drazen Pulanic; Marijo Vodanovic; Branka Golubic Cepulic
Journal:  Blood Transfus       Date:  2021-10-15       Impact factor: 5.752

7.  Refractory warm IgM-mediated autoimmune hemolytic anemia associated with Churg-Strauss syndrome responsive to eculizumab and rituximab.

Authors:  Mark P Chao; Jison Hong; Christian Kunder; Laura Lester; Stanley L Schrier; Ravindra Majeti
Journal:  Am J Hematol       Date:  2014-07-11       Impact factor: 10.047

8.  [Hemolytic anemia].

Authors:  A Tuchscherer; J Chemnitz
Journal:  Internist (Berl)       Date:  2015-09       Impact factor: 0.743

Review 9.  Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy.

Authors:  Sigbjørn Berentsen; Tatjana Sundic
Journal:  Biomed Res Int       Date:  2015-01-29       Impact factor: 3.411

Review 10.  Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia.

Authors:  W Barcellini; B Fattizzo
Journal:  Dis Markers       Date:  2015-12-27       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.